EUVIMEDEUVIMED entdecken
Crossref

Evaluation of doxorubicin and β‐lapachone analogs as anticancer agents, a biological and computational study

Itzel Mercado-Sánchez, Julio López, Rogelio Chávez-Rocha, Ismael Vargas-Rodríguez, Adán Bazán-Jiménez, Mariana Segovia-Mendoza, Heriberto Prado-Garcia, Miguel A Vázquez, Rocío García-Becerra, Marco A Garcia-Revilla iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Itzel Mercado-Sánchez und 9 weiteren Autor:innen. Beteiligte Einrichtung: División de Ciencias Naturales y Exactas, Departamento de Química, Universidad de Guanajuato, Guanajuato, Mexico. Hauptthemen laut MEDLINE: Naphthoquinones, Doxorubicin, DNA Topoisomerases, Type II, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM, Dirección General de Asuntos del Personal Académico (DGAPA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have conducted an experimental and computational evaluation of new doxorubicin ( 4a – c ) and β‐lapachone ( 5a – c ) analogs. These novel anticancer analogs were previously synthesized, but had not been tested or characterized until now. We have evaluated their antiproliferative and DNA cleavage inhibition properties using breast (MCF‐7 and MDA‐MB‐231) and prostate (PC3) cancer cell lines. Additionally, cell cycle analysis was performed using flow cytometry. Computational studies, including molecular docking, pharmacokinetic properties, and an analysis of DFT and QTAIM chemical descriptors, were performed to gain insights into the electronic structure and elucidate the molecular binding of the new β‐lapachone and doxorubicin analogs with a DNA sequence and Topoisomerase II (Topo II)α. Our results show that 4a analog displays the highest antiproliferative activity in cancer cell lines by inducing cell death. We observed that stacking interactions and hydrogen bonding are essential to stabilize the molecule‐DNA‐Topo IIα complex. Moreover, 4a and 5a analogs inhibited Topo's DNA cleavage activity. Pharmacodynamic results indicated that studied molecules have favorable adsorption and permeability properties. The calculated chemical descriptors indicate that electron accumulation in quinone rings is relevant to the reactivity and biological activity. Based on our results, 4a is a strong candidate for becoming an anticancer drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthoquinonesDoxorubicinDNA Topoisomerases, Type IIMolecular Docking SimulationAntineoplastic AgentsCell ProliferationHumansCell Line, TumorMCF-7 CellsDrug Screening Assays, AntitumorTopoisomerase II InhibitorsDNA Cleavage

Stichwörter der Autor:innen

cancerdoxorubicinfuran‐naphthoquinone derivativesmolecular dockingβ‐Lapachone

Substanzen

Naphthoquinonesbeta-lapachoneDoxorubicinDNA Topoisomerases, Type IIAntineoplastic AgentsTopoisomerase II Inhibitors

Autor:innen und Institutionen

  • División de Ciencias Naturales y Exactas, Departamento de Química, Universidad de Guanajuato, Guanajuato, Mexico.
  • Departamento de Química Orgánica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.
  • Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
  • Laboratorio de Onco-Inmunobiologia, Departamento de Enfermedades Crónico-Degenerativas, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Ciudad de México, Mexico.
  • Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico.
  • Programa de Investigación de Cáncer de Mama, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.

ORCID-Profile: Marco A Garcia-Revilla

Förderung

  • Consejo Nacional de Humanidades, Ciencias y Tecnologías
  • Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM
  • Dirección General de Asuntos del Personal Académico (DGAPA)
  • Universidad Nacional Autónoma de México
  • Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México

Zitieren

APA

Mercado-Sánchez, I., López, J., Chávez-Rocha, R., Vargas-Rodríguez, I., Bazán-Jiménez, A., Segovia-Mendoza, M., Prado-Garcia, H., Vázquez, M. A., García-Becerra, R., & Garcia-Revilla, M. A. (2024). Evaluation of doxorubicin and β‐lapachone analogs as anticancer agents, a biological and computational study. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14596

Vancouver

Mercado-Sánchez I, López J, Chávez-Rocha R, Vargas-Rodríguez I, Bazán-Jiménez A, Segovia-Mendoza M, et al. Evaluation of doxorubicin and β‐lapachone analogs as anticancer agents, a biological and computational study. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14596

BibTeX
@article{MercadoSnchez2024,
  author = {Mercado-Sánchez, Itzel and López, Julio and Chávez-Rocha, Rogelio and Vargas-Rodríguez, Ismael and Bazán-Jiménez, Adán and Segovia-Mendoza, Mariana and Prado-Garcia, Heriberto and Vázquez, Miguel A and García-Becerra, Rocío and Garcia-Revilla, Marco A},
  title = {Evaluation of doxorubicin and β‐lapachone analogs as anticancer agents, a biological and computational study},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14596}
}
Kostenlos starten →